Guillaume Lacroix

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial

Yann Vano, Réza Elaidi, Mostefa Bennamoun et al. · The Lancet Oncology · 2022 · 136 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Cytomegalovirus infection in severe burn patients monitoring by real-time polymerase chain reaction: A prospective study

J. Bordes, J Maslin, Bertrand Prunet et al. · Burns · 2011 · 41 citations

Medicine, Clinical Sciences, Surgery +14

Maintenance of normothermia during burn surgery with an intravascular temperature control system: A non-randomised controlled trial

Bertrand Prunet, Yves Asencio, Guillaume Lacroix et al. · Injury · 2010 · 34 citations

Medicine, Surgery, Burn Surgery +11

A Prospective Randomized Trial of Two Safety Peripheral Intravenous Catheters

Bertrand Prunet, Éric Meaudre, Ambroise Montcriol et al. · Anesthesia & Analgesia · 2008 · 31 citations

Pharmacy, Injury Prevention, Anesthesia +15

Comparison of the Berlin definition with the American European Consensus definition for acute respiratory distress syndrome in burn patients

Julien Bordes, Guillaume Lacroix, Pierre Esnault et al. · Burns · 2014 · 30 citations

Medicine, Internal Medicine, Burn Surgery +11